Rock Springs Capital Management LP Q2 2022 Filing

Filed August 15, 2022

Portfolio Value

$3.4B

Holdings

131

Report Date

Q2 2022

Filing Type

13F-HR

All Holdings (131 positions)

#	Stock	Shares	Value	% Portfolio
101	XLOXILIO THERAPEUTICS INC	1,362,878	$4.0M	0.12%
102	—GAMIDA CELL LTD	2,175,000	$3.9M	0.11%
103	—PARATEK PHARMACEUTICALS INC	1,734,037	$3.3M	0.10%
104	TVTX 2.5 09/15/25TRAVERE THERAPEUTICS INC	3,250,000	$3.2M	0.09%
105	—BCLS ACQUISITION CORP	309,000	$3.1M	0.09%
106	OKURRENEO PHARMACEUTICALS INC	1,143,185	$3.0M	0.09%
107	SPRBSPRUCE BIOSCIENCES INC	1,622,689	$2.8M	0.08%
108	MGNXMACROGENICS INC	954,728	$2.8M	0.08%
109	FATEFATE THERAPEUTICS INC	110,000	$2.7M	0.08%
110	—THESEUS PHARMACEUTICALS INC	437,329	$2.4M	0.07%
111	CGENCOMPUGEN LTD	1,289,990	$2.4M	0.07%
112	—JIYA ACQUISITION CORP	206,200	$2.0M	0.06%
113	—FUSION PHARMACEUTICALS INC	809,854	$2.0M	0.06%
114	PRLDPRELUDE THERAPEUTICS INC	368,959	$1.9M	0.06%
115	FULCFULCRUM THERAPEUTICS INC	384,590	$1.9M	0.05%
116	OVASUSDTEMPEST THERAPEUTICS INC	823,654	$1.8M	0.05%
117	—PHASEBIO PHARMACEUTICALS INC	2,774,869	$1.7M	0.05%
118	EPIEURESSA PHARMA INC	524,944	$1.7M	0.05%
119	AGLEUSDAEGLEA BIOTHERAPEUTICS INC	3,072,034	$1.6M	0.05%
120	—ACELRX PHARMACEUTICALS INC	6,329,202	$1.5M	0.04%
121	—RADIUS HEALTH INC	1,500,000	$1.5M	0.04%
122	—THERAVANCE BIOPHARMA INC	1,500,000	$1.4M	0.04%
123	NBIX 2.25 05/15/24NEUROCRINE BIOSCIENCES INC	1,000,000	$1.3M	0.04%
124	VIGLVIGIL NEUROSCIENCE INC	471,958	$1.2M	0.04%
125	—VINCERX PHARMA INC	814,194	$1.1M	0.03%
126	—IMARA INC	842,402	$1.0M	0.03%
127	BCELATRECA INC	462,530	$828K	0.02%
128	APLTAPPLIED THERAPEUTICS INC	701,680	$665K	0.02%
129	SPROSPERO THERAPEUTICS INC	770,710	$571K	0.02%
130	NVRO 2.75 04/01/25NEVRO CORP	500,000	$466K	0.01%
131	NUVB/WSNUVATION BIO INC	134,028	$38K	0.00%

PreviousPage 2 of 2